Membership

September 2014 Newsletter


September 2014 Newsletter

 
Table of Contents

  President Corner
Tony Mok Photo
Tony S.K. Mok, IASLC President

It was only 8:00am when I enter the meeting room with a nervous heart. I asked myself, "What if it is half empty?"

This is a new venture, a collaborative joint symposium between IASLC and CSCO (Chinese Society of Clinical Oncology). At the CSCO Annual meeting we wanted to establish a new International Track using English as the only language and have invited IASLC to be a partner in this Lung Cancer Symposium. We were nervous as we weren't sure if the Chinese speaking audience would receive it well. For such we asked Fred (Hirsch), Pasi (Janne) and Robert (Doeble) to represent IASLC; and Zhou Cai Cun and I (wearing dual hats) to represent CSCO. We were hoping the high quality science would overcome the language barrier.

In fact the room was packed with many managing with only standing space. Good science is still the reason why we gather. I was most delighted, not only by the full attendance, but also by the engaging participation from the audience. They asked sharp questions and pointing out the debatable issue...in English. This is a sign of success and has illustrated how IASLC has reached out to the world. As Dr. Paul Bunn always says, "The "I" of IASLC stands for "International". And he is right, as always.

   CEO
Fred Hirsch
Fred R. Hirsch, IASLC Chief Executive Officer

Dear Colleagues,

While many activities within IASLC are ongoing, the last month has notably been a success for IASLC in Asia. A very successful IASLC workshop on personalized therapy in lung cancer was held in Shanghai under the leadership of Professor Caicun Zhou, and a few weeks ago the Chinese Society of Clinical Oncology (CSCO) held its Annual Meeting with more than 20,000 participants. The program included an IASLC/CSCO session on molecular targeted-therapies in NSCLC. Thanks to Professor Yi-Long Wu, who is now also President of CSCO, and to the IASLC President Professor Tony Mok, who is now also vice-president of CSCO, for establishing this very exciting session at CSCO. The IASLC/CSCO session drew a fully packed audience.

The IASLC webinar series is going very well and kudos to Dr. R. Govindan for coordinating this activity.

The preparation for the World Conference in Denver, Colorado next September is now in full swing, and a very exciting program will be announced shortly. We encourage members and industry to already now start preparing for scientific abstract submissions. Many new program tracks have been developed, such as for Nurses and Allied Health Professionals and Advocacy. An educational track for community-based practices has also been developed. Very soon our new International Mentoring Fellowship Program for investigators in developing countries will be launched. IASLC will bring 10 fellows from developing countries to the WCLC, and thereafter invite the same fellows to stay one week at a regionally-based academic institution under defined mentorship depending on clinical/research interests.

IASLC will also pay attention to our new initiative focusing on small cell lung cancer (SCLC). In April 2015 an expert meeting will be held in New York City, where the newest science will be presented and discussed and a roadmap for future SCLC research will be outlined. Hopefully, this meeting will lead to international collaborations in a strongly needed field.

Increasing membership has high priority for IASLC. A membership survey is in preparation and we hope as many members as possible will respond and give us feed-back so the most optimal future strategy can be planned.

Last, but not least, IASLC will encourage as many of our members to acquire our new “Multidiciplinary Textbook”. This is the most comprehensive textbook in thoracic malignancies, and the book is very suitable for educational purposes both in industry and in academia. For further information, please, see www.iaslc.org.

2014 Chicago Multidisciplinary Symposium in Thoracic Oncology
Members of the IASLC, American Society of Clinical Oncology, the American Society for Radiation Oncology, and the University of Chicago have designed an outstanding two-and-a-half day symposium.
October 30 - November 1 2014 | Chicago, Illinois | View Details

 

 

 Asian Pacific Lung Cancer Conference (APLCC)
The Asian Pacific Lung Cancer Conference will bring together medical professionals In Malaysia to discuss the latest in lung cancer research and treatment.
November 6 - 8 2014 | Malaysia | View Details

 

 

15th Annual Targeted Therapies of The Treatment of Lung Cancer
The invitation-only meeting gathers the top scientists to discuss the latest advances in the treatment of lung cancer with targeted therapies. 
February 18 - 21 2015 | Santa Monica, CA | View Details

European Lung Cancer Conference - ELCC 2015
IASLC and ESMO are pleased to announce that the European Lung Cancer Conference (ELCC), will become an annual meeting as of 2015.
April 15 - 18 2015 | Geneva, Switzerland | View Details

 The 1st Announcement is now available for the 16th World Conference on Lung Cancer in Denver, Colorado, USA September 6-9, 2015.
The 16th World Conference on Lung Cancer will be one of the largest international gatherings of multidisciplinary experts in the field of lung cancer and thoracic malignancies. Those interested in all aspects of lung cancer and thoracic malignancies including surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, basic research scientists, nurses, allied-health professionals, and patient advocates are encouraged to attend this extraordinary conference. Read More

WEBINARS

Grand Rounds: Session #9 - What’s New in the Management of EGFR-mutant NSCLC?
October 8, 2014 at 8:00PM EDT5
The Ninth webinar in the series: IASLC Grand Rounds Series - What's New in the Management of EGFR-mutant NSCLC? More

Multidisciplinary Lung Cancer Tumor Board
Wednesday October 22, 2014 11:00AM EDT/9:00AM MDT
ADVANCED RADIATION TECHNOLOGY COMMITTEE ANNOUNCES:
A LIVE WEBINAR More

 

 
 
The IASLC Multidisciplinary Approach to Thoracic Oncology
Do not miss out on your opportunity to have the premier educational resource on lung cancer at your fingertips. The book is available in soft-cover and digital access. The soft-cover is available for $225 (plus Shipping & Handling), digital subscription for $225 or get both for $300 (plus Shipping & Handling). Click Here to make your purchase.

 
 

 November Lung Cancer Awareness

 

Join IASLC in helping raise awareness to Lung Cancer for November’s Lung Cancer Awareness Month.  Lung cancer accounts for about 27% of all cancer deaths and is by far the leading cause of cancer death among both men and women. Each year, more people die of lung cancer than of colon, breast, and prostate cancers combined.  It is important that IASLC members help communicate the vast health threat that lung cancer poses around the world.  However, it is clear that the media and much of the public around the world are also unaware of the hope that new research, diagnosis and treatment breakthroughs in the last 10 years have brought to patients and their families. 

 IASLC is asking its members to engage with local media and advocacy groups to help bring light to this devastating disease, and will be providing some resources for you to use during November.  These resources will be communicated to members via the Member Newsletter and dedicated email communications during October and November, along with a social media campaign to gain awareness among the public.  IASLC and the lung cancer advocacy community will be using #LCAM14 on social media to consolidate efforts during November.  For more information on how you can become more active in helping bring attention to Lung Cancer, contact, Rob Mansheim, IASLC Director of Communications or visit our advocacy page online at www.iaslc.org.

Abstracts for LALCA 2014 now published in the JTO.

DENVER – The International Association for the Study of Lung Cancer (IASLC) is pleased to announce that scientific abstracts for the 6th Latin American Conference on Lung Cancer (LALCA) are now available online through the Journal of Thoracic Oncology.

 

iPAD, iPhone and Android Apps - IASLC Atlas of ALK Testing in Lung Cancer
English, Spanish, Japanese and Chinese translations on the FREE moblie app. More

Personalized Therapy of Lung Cancer Workshop was held in Shanghai, China on September 5, 2014.
The workshop on personalized therapy of lung cancer is an IASLC educational event designed to engage medical, surgical and radiation oncologists, pulmonologists, nurses and translation research scientists. More

 

 

The 17th Annual Meeting of Chinese Society of Clinical Oncology (CSCO) September 17-21.
Adhering to CSCO tenet, the conference provided great opportunities for worldwide communication and cooperation on clinical oncology.

 


nEWS

 

Highlighted JTO Articles

 

NCI/FDA lung cancer workshop leads to the innovatively designed clinical trials Lung-MAP and ALCHEMIST, the first “Master Protocol” trials

DENVER – The recent launch of two clinical trials offer innovative study designs for patients with lung cancer. These clinical trials are the direct result of a National Cancer Institute (NCI) sponsored workshop chaired by Drs. Fred R. Hirsch, Shakun Malik and Claudio Dansky- Ullman, that brought together the NCI Thoracic Malignancies Steering Committee, the US Food and Drug Administration (FDA), academicians, clinicians as well as industry and government stakeholders to discuss issues and challenges related to clinical trial design and biomarkers for lung cancer targeted-therapies.

Less costly to screen for and treat early-stage lung than to treat late-stage lung cancer.

DENVER – The average cost to screen high-risk individuals for developing lung cancer with low-dose computed tomography (LDCT) plus the average cost of curative intent treatment, like surgery, is lower than the average cost to treat advanced stage lung cancer, which quite rarely results in a cure.

Modest acute changes in cardiac biomarkers and electrocardiogram findings following thoracic radiation therapy.

DENVER – There were only modest acute changes in cardiac biomarkers and electrocardiograms and there were no clinically significant cardiac events in patients with high-dose radiation exposure to the heart following thoracic radiation therapy (RT) and short-term follow-up.

 

 
 
 

Membership

Member Feedback Requested – Chance to win an iPad when you complete the IASLC 2014 Membership Survey

Thank you for being a member of IASLC! To help evaluate the needs of IASLC’s growing membership, IASLC seeks feedback annually on membership benefits, programs, and services.  The 2014 Member Feedback Survey has been distributed to all active members from 2013 and 2014.  All survey responders will be entered into a random drawing to win an Apple iPad. In 2013, IASLC member, Dr. Hideyuki Nakagawa from Japan was the winner randomly selected to receive a free iPad. Please note the survey link is emailed individually to all members, and will be anonymous, unless you provide your contact details during the survey.   If you did not receive the survey in your email inbox, please contact membership@iaslc.org immediately to have it re-sent to you.  The anonymous survey will take members no longer than 5 minutes to complete. 

 

IASLC Announces Patient Advocacy Travel Awards for 2015 World Conference on Lung Cancer in Denver, CO, USA

The International Association for the Study of Lung Cancer (IASLC) has opened the application process for lung cancer patient advocates to apply for Advocacy Travel Awards. Awardees receive a travel stipend, free conference registration, up to four nights’ accommodations, and a free IASLC Membership for 2016. 

 “For the World Conference on Lung Cancer in 2015, we hope to engage and receive more applications from other regions of the world, including Europe, Asia, the Middle East and Latin America. We know that the cost of travel can be a deterrent, and we hope these travel awards will encourage more survivors and patient advocates from around the world to apply” says Glenda Colburn, chair of the IASLC Patient Advocacy Committee and a Director at Lung Foundation Australia.   (Read More)

 

IASLC Welcomes New Members From LALCA 2014 and Other Regions in 2014

IASLC welcomes the support of more than 600 new members in 2014.  The new members represent Latin America, Europe, Asia, North America and the Rest of the World, including new Regular and Fellow/Trainee members who joined during attendance at the Latin American Conference on Lung Cancer 2014 in Lima, Peru.  The primary specialty most represented among this year’s new members is Medical Oncology (31%), followed by Thoracic Surgery (17%) and then Pulmonary Medicine (12%), which is relatively comparable to IASLC’s overall membership by specialty.  In order to foster collaboration and collegiality among members, IASLC will share the names of new members who join IASLC in monthly newsletters.  All active members may login online to search the online member directory by name, institution, location or specialty and contact other IASLC members.  We appreciate the support of our new and returning members in our mission to conquer lung cancer worldwide, and cordially welcome these members into the IASLC family. 

 

Welcome new members to IASLC!
Help us welcome these new members to IALSC! Starting this month we are bringing back a part of the newsletter that has disappeared for a while. Expect to see new members monthly. Here is a list of pervious new members from the past few months. Click more to see full list. More
Argentina
Alfredo Larravide, Medical Oncology

Australia
Laird Cameron, Medical Oncology
Chee Yoong Choy, Pulmonary Medicine
Renae Grundy, Nursing (Contiuned)

 


IASLC MEMBERS: If you have a newsworthy item or career change you would like featured, please email Rob Mansheim for consideration.

IASLC Regent News

Regent’s Name:  Gyula Ostoros (Budapest, Hungary)

Region Covered: Central Europe, including: Austria, Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, Slovenia

The incidence and mortality rates of lung cancer are high in countries of Central Europe with Hungary having the world-wide highest rates.The economic situation differs between the nine countries. Although all countries are EU members, there are significant differences in the economy and the health insurance between the countries. While Austria is quite a rich country, other countries such as Bulgaria or Romania have limited resources. 

Several strategies are ongoing to decrease the lung cancer burden in our countries. The Central European Lung Cancer Conferences have a long-standing traditions ad serve as both scientific and educational events. The 14th Central European Lung Cancer Conference will take place in Vienna, 29 November – 2 December 2014. The Conferences have been organized by lung cancer experts (Drs. Eberhardt, Jassem, Klastersky, Kovacs, Petruzelka, Pirker, Stahel, Vansteenkiste and in the past also Hansen, Zatloukal, Gregor). 

The Central European Initiative against Lung Cancer Meeting is another strategy. The Inaugural Workshop was held in April 2013 in Vienna and discussed future strategies for decreasing the lung cancer burden in Central Europe, and the Second Workshop in 2014.  There is also the Central  European Lung Cancer Patient Network (CALPANET), which has a meeting in November, in Vienna. The IASLC 17th World Conference on Lung Cancer Conference in 2016 in Vienna will be another important event for our region and several doctors of our region will be involved in its planning.  I encourage all pulmonologists and oncologists to actively take part in the Conference.

Other goals in this region are to start and anti-smoking program with educational materials, to increase the number of regular members of IASLC, and to increase the number of participants of the 17th WCLC in Vienna, Austria December 4-7, 2016.  

Message to Region (Hungarian)

A Közép Európai régióban a tüdőrák rendkívüli problémát jelent. Igen magas az előfordulási aránya, melynek oka nem csak a dohányzási szokásokban, hanem az életmódban, a stresszel teli életvitelben, az életszínvonalbeli különbségekben is rejlik. Igen fontos felmérni a tüdőrákkal kapcsolatos közös problémákat mind a betegség primer és szekunder prevenciója, mind pedig a diagnosztika, illetőleg a terápiás lehetőségek vonatkozásában is.

If you have questions, or wish to contact Dr. Ostoros, please email: ostorosgyula@freemail.hu

 More information on the Council of Regents 
Please invite a Fellow, Resident or Trainee today!  


IASLC MEMBERS: If you have a career or funding opportunity you would like featured in a future newsletter, please email Rob Mansheim for consideration.


This Month's Contributors:
IASLC Newsletter Editor: Anne Tsao, MD - USA

Fred R Hirsch; Tony S.K. Mok;

IASLC Newsletter Subcommittee:

Ingrid Du Rand, UK; Glenda Colburn, Australia; Geoffrey Oxnard, USA; Sai-Hong Ou, USA; Ross Soo, Singapore; Carolyn Clary-Macy, USA; Richard Booton, UK; Heather Wakelee, USA; Rob Mansheim, Staff Liaison

Are you interested in getting more involved in IASLC?  In order to meet increased communication needs, the IASLC is seeking to expand the Communications Committee. IASLC is especially interested in volunteer members who are active on social media.  Please use the online form to self-nominate for the position.  If you have questions, please don't hesitate to contact Rob Mansheim at Rob.Mansheim@iaslc.org.

IASLC MEMBERS: If you have a newsworthy item or career opportunity you would like featured, please email Rob Mansheim for consideration.